Blend Labs, Inc. (NYSE:BLND) Receives Consensus Rating of “Moderate Buy” from Brokerages

Shares of Blend Labs, Inc. (NYSE:BLND) have received an average rating of “Moderate Buy” from the eight research firms that are presently covering the stock, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, two have given a hold recommendation, four have given a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12-month target price among brokerages that have updated their coverage on the stock in the last year is $4.8833.

A number of equities research analysts recently commented on BLND shares. Wall Street Zen upgraded Blend Labs from a “sell” rating to a “hold” rating in a research report on Sunday, August 17th. Canaccord Genuity Group reiterated a “buy” rating and issued a $5.25 price objective on shares of Blend Labs in a research note on Friday, August 22nd. UBS Group decreased their target price on shares of Blend Labs from $4.00 to $3.50 and set a “neutral” rating for the company in a research report on Friday, August 8th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Blend Labs in a research report on Wednesday. Finally, Keefe, Bruyette & Woods decreased their price objective on Blend Labs from $4.00 to $3.75 and set a “market perform” rating for the company in a report on Friday, August 8th.

Blend Labs Price Performance

NYSE BLND opened at $3.16 on Friday. The company has a market cap of $820.53 million, a price-to-earnings ratio of -21.07 and a beta of 1.24. The stock’s fifty day moving average price is $3.60 and its 200 day moving average price is $3.47. Blend Labs has a 1 year low of $2.63 and a 1 year high of $5.53.

Blend Labs (NYSE:BLND) last posted its quarterly earnings results on Thursday, August 7th. The company reported ($0.03) earnings per share for the quarter, missing the consensus estimate of $0.02 by ($0.05). The business had revenue of $31.52 million during the quarter, compared to analyst estimates of $31.93 million. Blend Labs has set its Q3 2025 guidance at EPS. Research analysts expect that Blend Labs will post -0.19 earnings per share for the current year.

Insider Buying and Selling

In other news, insider Brian Kneafsey sold 25,000 shares of Blend Labs stock in a transaction that occurred on Friday, August 15th. The shares were sold at an average price of $2.87, for a total transaction of $71,750.00. Following the completion of the transaction, the insider directly owned 696,598 shares of the company’s stock, valued at $1,999,236.26. The trade was a 3.46% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Nima Ghamsari sold 311,886 shares of the business’s stock in a transaction on Thursday, August 14th. The shares were sold at an average price of $2.90, for a total transaction of $904,469.40. Following the completion of the transaction, the insider owned 5,754,051 shares of the company’s stock, valued at approximately $16,686,747.90. This represents a 5.14% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 381,886 shares of company stock valued at $1,135,369 over the last three months. 35.52% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the company. Marshall Wace LLP boosted its stake in shares of Blend Labs by 157.6% during the 2nd quarter. Marshall Wace LLP now owns 2,522,141 shares of the company’s stock worth $8,323,000 after acquiring an additional 1,543,220 shares in the last quarter. Vanguard Group Inc. raised its holdings in Blend Labs by 4.6% in the 1st quarter. Vanguard Group Inc. now owns 17,586,601 shares of the company’s stock worth $58,915,000 after purchasing an additional 775,091 shares during the period. Metavasi Capital LP boosted its position in Blend Labs by 15.6% during the first quarter. Metavasi Capital LP now owns 5,554,101 shares of the company’s stock worth $18,606,000 after purchasing an additional 750,000 shares in the last quarter. Panagora Asset Management Inc. acquired a new stake in Blend Labs in the second quarter valued at approximately $2,466,000. Finally, AQR Capital Management LLC increased its position in shares of Blend Labs by 84.5% in the second quarter. AQR Capital Management LLC now owns 1,629,509 shares of the company’s stock valued at $5,377,000 after buying an additional 746,213 shares in the last quarter. Institutional investors and hedge funds own 52.56% of the company’s stock.

About Blend Labs

Blend Labs, Inc engages in the provision of cloud-based software platform solutions for financial services firms in the United States. It operates in two segments, Blend Platform and Title365. The company's Blend Builder Platform offers a suite of products that powers digital-first consumer journeys for mortgages, home equity loans and lines of credit, vehicle loans, personal loans, credit cards, and deposit accounts; and offers mortgage products to facilitate the homeownership journey for consumers comprising close, income verification for mortgage, homeowners' insurance, and realty.